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Transcriptional repression within a complex modular promoter may play a key role in determining the
action of enhancer elements. In human cytomegalovirus, the major immediate-early promoter (MIEP) locus
contains a highly potent and complex modular enhancer. Evidence is presented suggesting that sequences of
the MIEP between nucleotide positions 2556 and 2673 function to prevent transcription activation by
enhancer elements from the UL127 open reading frame divergent promoter. Transient transfection assays of
reporter plasmids revealed repressor sequences located between nucleotides 2556 and 2638. The ability of
these sequences to confer repression in the context of an infection was shown using recombinant viruses
generated from a bacterial artificial chromosome containing an infectious human cytomegalovirus genome. In
addition to repressor sequences between 2556 and 2638, infection experiments using recombinant virus
mutants indicated that sequences between 2638 and 2673 also contribute to repression of the UL127
promoter. On the basis of in vitro transcription and transient transfection assays, we further show that
interposed viral repressor sequences completely inhibit enhancer-mediated activation of not only the homol-
ogous but also heterologous promoters. These and other experiments suggest that repression involves an
interaction of host-encoded regulatory factors with defined promoter sequences that have the property of
proximally interfering with upstream enhancer elements in a chromatin-independent manner. Altogether, our
findings establish the presence of a boundary domain that efficiently blocks enhancer-promoter interactions,
thus explaining how the enhancer can work to selectively activate the MIEP.
The major immediate-early promoter (MIEP) enhancer re-
gion of cytomegalovirus (CMV) is required for optimal infec-
tion (3) and plays an important role in determining the cell
type tropism and state of activation in vivo (4, 5, 24, 28). The
MIEP is highly complex and contains one of the most potent
transcriptional enhancers known to date (7; reviewed in refer-
ence 20). Previous studies have demonstrated the importance
of a wide variety of positive cis-acting enhancer modules in
promoting high levels of transcription from the human CMV
(HCMV) MIEP. In addition, the viral IE2 (IE86 and L40)
proteins act as autorepressors of the HCMV MIEP by binding
the cis repression sequence (14, 30, 34, 39, 41, 42). The location
of this sequence, between the initiation site of transcription
and the TATA box sequence, enables IE2 proteins to compet-
itively block the recruitment of RNA polymerase II at the
MIEP (31, 42). Repression is also predicted to be essential for
establishing stringent regulation of the MIEP enhancer, which
is likely to be an important feature in determining temporal
and cell-type-specific patterns of viral gene expression as well
as preventing promiscuous promoter interactions.
In the species-specific mouse CMV (MCMV), a similarly
complex but distinct enhancer/promoter region is involved in
controlling expression from its major immediate-early (MIE)
genes (15). A divergent promoter upstream from its MIEP
drives the expression of the MCMV ie2 gene (Fig. 1) (37). This
gene is dispensable for growth in tissue culture and in vivo and
comes under control of the nearby enhancer, thereby display-
ing IE kinetics of expression (9, 35). The observation that the
MCMV enhancer plays a dual role in regulating ie1 and ie2
expression is not unexpected since by definition enhancers
function equally well in either orientation. Similar to the or-
ganization of MCMV MIE locus, the genome sequence from
HCMV (11) identified a divergent open reading frame (ORF)
(UL127) in close proximity to the enhancer (Fig. 1) and which
overlaps the modulator domain of the human MIEP (Fig. 2A).
While the HCMV UL127 ORF is dispensable for replication in
tissue culture, it does not appear to have any significant ho-
mology with the mouse viral ie2 gene (36, 37). In contrast to
the MCMV ie2 gene, expression of UL127-encoding transcript
is not detected upon infection of human foreskin fibroblasts
(HFF cells) by HCMV (10). The UL127 promoter region con-
tains an excellent TATA box (10 out of 11 nucleotides [nt]
match with the MIEP TATA box [Fig. 1]) and binds CTF-1/
NF-1 at the expected CAAT box position (18). Thus, the ob-
servation for inactivity of this divergent promoter is unex-
pected due to the strong potency of the CMV enhancer and
raises the question as to why the enhancer is unable to influ-
ence expression of the UL127 promoter site. It is conceivable
that repressors stringently regulate the UL127 promoter. To
investigate this issue, we have examined the requirement of
cis-acting sequences in the promoter-proximal region of
UL127 for limiting enhancer action.
Here, we present evidence that sequences located between
2556 and 2673 of the MIEP serve to completely block en-
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hancer interactions with the UL127 promoter site. This region
therefore plays an important role in defining the boundary of
action of the MIEP enhancer in HCMV.
MATERIALS AND METHODS
Cells. The cell lines U373-MG, HeLa, NT-2/D1, and MRC-5, as well as the
HFF cells, were grown in Dulbecco’s modified Eagle medium supplemented with
2 mM glutamine, 100 U of penicillin per ml, 100 mg of gentamicin per ml, and
10% (vol/vol) fetal bovine serum.
Plasmid constructions and transfections. Plasmid pSnaB-Bam(HI)CAT was
constructed by inserting a BamHI/SpeI fragment from pMIEP(HIB)CAT (17)
into BamHI/SpeI-digested pSnaB-BamCAT. Plasmid pSnaB-BamCAT contains
regulatory sequences of the HCMV MIE gene from nt 2243 to 2741 linked to
the chloramphenicol acetyltransferase (CAT) gene. To construct pGACC(2531)
and pGACC(2673), recombinant plasmid pGACC was generated by inserting
annealed oligonucleotides G53 (59-GATCCATTGGTTATATAGCATAACTA
GTAAGCTTCTACGTAC-39) and G52 (59-AGCTGTACGTAGAAGCTTACT
AGTTATGCTATATAACCAATG-39), containing SnaBI, HindIII, and SpeI
sites, into BamHI/HindIII-digested pMIEP(266/155)CAT (42). A HindIII/
SnaBI fragment from D1 and pR55 (kindly provided by B. Fleckenstein) was
cloned into pGACC digested with HindIII/SnaBI to create pGACC(2531) and
pGACC(2673), respectively. Plasmids pGACC(2531) and pGACC(2673)
were digested with SnaBI and BamHI and ligated into SmaI/BglII-digested
pGL3-Basic (Promega, Madison, Wis.) to create pGL3(2531) and pGL3(2673),
respectively. To construct pE(266/1112)CAT and pEusr(266/1112)CAT, a
190-bp BamHI/HindIII fragment from pMIEP(266/1112) (44) that contains
HCMV MIEP sequences from 266 to 1112 was inserted into BamHI/
HindIII-digested pGACC(2531) and pGACC(2598), respectively. Plasmids
pGL3(2634), pGL3(2581), pGL3(2556), and pGL3(2531) were constructed
using the PCR primers promExt-1 (59-TGTACGTAGATGTACTGCCAAGT-39),
promExt-2 (59-TGAAGCTTGGTCATTAGTTCATAGCCAT-39), promExt-3
(59-TGAAGCTTAGTTATTAATAGTAATCAATTAC-39), promExt-4 (59-TG
AAGCTTCATGTTGACATTGATTATTGA-39), and promExt-5 (59-TGAAGC
TTTTTATATTGGCTCATGTCCAAC-39). All PCRs were performed with
pMIEP(21145/1112)CAT (19) and primer promExt-1. Primers promExt-2,
promExt-3, promExt-4, and promExt-5 were used to generate pGL3(2634),
pGL3(2581), pGL3(2556), and pGL3(2531), respectively. Primer promExt-1
contains a 59 SnaBI linker, while primers promExt-2, promExt-3, promExt-4, and
promExt-5 contain a 59 HindIII linker. The corresponding PCR products were
digested with SnaBI and HindIII and inserted into SnaBI/HindIII
pGACC(2531). The SnaBI/BamHI fragments excised from the recombinant
plasmids generated were then inserted into SmaI/BglII-digested pGL3-Basic to
generate plasmids pGL3(2634), pGL3(2581), pGL3(2556), and pGL3(2531).
Plasmids pGL3(D2531/2638) and pGL3(D2531/2609) were made by utilizing
PCR primers promRev-1 (59-TGGGATCCCATTGGTTATATA-39), prom-
Rev-2 (59-TGTGATCACATATTATGATATGG-39), and promRev-3 (59-TGT
FIG. 1. Schematic diagrams of the HCMV and MCMV genomes. Fragments containing the MIE regions are expanded below the corresponding regions of the
genomes. Locations and direction of transcription of the ORFs for the MIE genes ie1, ie2, and ie3 and the potential UL127 ORF are indicated. The gray box depicts
the enhancer. The TATA box sequences of the different ORFs are shown. The diagram is not drawn to scale.
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GATCAGTCAACATGGCGGT-39). All PCRs were performed with
pMIEP(21145/1112)CAT and primer promRev-1. Primer promRev-2 was used
to create pGL3(D2531/2638), and promRev-3 was used to generate
pGL3(D2531/2609). Primer promRev-1 contains a 59 BamHI linker, while
primers promRev-2 and promRev-3 contain a 59 BclI linker. The two PCR
products generated were cloned between the SpeI and the BamHI sites of
pGACC(2531). SnaBI/BamHI fragments were excised from the two recombi-
nant plasmids constructed and inserted into SmaI/BglII-digested pGL3-Basic.
The b-galactosidase expression vector pRSV-b-gal and the luciferase expression
vector pRL-tk (Promega) were used as internal controls in transfection assays.
Transfections were performed by the calcium phosphate precipitation method
as described previously (19). Cell lysates were prepared 30 h after transfection.
b-Galactosidase and CAT assays were performed as previously described (2).
Luciferase activity was determined according to the Promega’s Dual-Luciferase
reporter assay system technical manual. The activity of the experimental lucif-
erase reporters was normalized to the activity of the internal control pRL-tk. For
CAT assays, cell extracts containing the same amount of b-galactosidase were
used. CAT activity was quantitated by using a Molecular Dynamics Phospho-
rImager system with ImageQuant software.
BAC mutagenesis and virus construction. For generation of recombinant
viruses UL127-GFP1, UL127-GFP10, and UL127-GFP7, three plasmids were
constructed that contained a green fluorescent protein (GFP) reporter gene from
pEGFP-C1 (Clontech, Palo Alto, Calif.) downstream of the UL127 sequences
which were isolated from reporter plasmids pGACC(2673), pGACC(2531/
2638), and pGACC(2531), respectively (Fig. 2 and 6). Note that in these
constructs the GFP gene was inserted as a separate ORF upstream of the UL127
ORF but downstream of the UL127 promoter sequences. Briefly, enhanced GFP
(EGFP) primers 59-GGCCTGCAGATCTGCTAGCGCTACCGGTCGCCA-39
and 59-GGCCTGCAGTTTAAACTCACTTGTACAGCTCGTCCATGCC-39,
containing BglII and PmeI sites, respectively, were used to PCR amplify the
EGFP gene. The resultant PCR fragment was digested with PstI and inserted
into the NsiI site at position 2755 of pMIEP(21145/1112)CAT. Next a BglII site
(introduced from the EGFP primer) and the SnaBI site of the wild-type (wt)
MIEP sequence (at position 2243) were used to replace the wt MIEP sequence
Fig. 2—Continued.
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with BamHI/SnaBI fragments containing the deletion mutations of pGACC
(2673), pGACC(2531/2638), and pGACC(2531), respectively. A tetracycline
resistance gene flanked with FRT sites was excised from plasmid pCP16 (13) and
inserted into a unique PmeI site downstream of the EGFP gene. The resulting
constructs were digested with PstI (21145) and EagI (178), generating frag-
ments that contained one of the three different MIEP sequences each, the GFP
gene, the tetracycline resistance gene, and 385 bp of downstream sequences
comprising the UL127 ORF. Recombination between the linear fragments and
the HCMV bacterial artificial chromosome (BAC) plasmid pHB5 (6) was per-
formed in the recombination-proficient Escherichia coli strain JC8679 according
to a recently described mutagenesis procedure (44). Minipreparations of BAC
DNA isolated from 10-ml bacterial cultures were prepared and characterized by
digestion with restriction enzymes SpeI, SalI, and SnaBI. HCMV BACs that had
received the mutation were then transformed in the recombination-deficient E.
coli strain DH10B. Excision of the tetracycline resistance cassette with Flp
recombinase was performed essentially as described elsewhere (13) and con-
firmed by restriction enzyme analysis. In addition, the regions of interest were
sequenced in the different BACs. Sequences were as expected for all recombi-
nants except in BAC UL127-GFP10 between nt 2688 and 2676 relative to the
transcription start site of the MIEP that contain 10 mismatched nucleotides,
disrupting the NF-1 site 59 proximal to the UL127 TATA box. Midipreparations
of BACs were used to transfect MRC-5 cells for generation of infectious recom-
binant virus as described previously (6). Infection of HFF cells was used to
generate viral stocks, and titers of infectious virus were determined by standard
methods.
In vitro runoff transcription assay. Transcription reactions (25 ml) were per-
formed with nuclear extracts prepared from HeLa cells as described previously
(18). The templates pMIEP(266/1112), pE(266/1112), and pEusr(266/1112)
were linearized with EcoRI and used in the transcription reactions at a concen-
tration of 25 mg/ml. Transcript products were analyzed by electrophoresis on a
denaturing (8.3 M urea) 6% polyacrylamide gel. Relative levels of transcription
were quantitated using a PhosphorImager (Molecular Dynamics). Poly(U) poly-
merase activity present in the nuclear extract was used as an internal standard to
account for variability between samples.
Reverse transcriptase (RT)-mediated PCR (RT-PCR). HFF cells were in-
fected with the different recombinant viruses at a multiplicity of infection (MOI)
of 0.1 PFU/cell. Total RNA was isolated at 13 h postinfection (hpi) by using the
RNAzol B method (Tel-Test, Inc., Friendswood, Tex.) according to the manu-
facturer’s protocol. RNA samples were treated with RNase-free DNase I for 15
min at room temperature, and the DNase was inactivated at 65°C for 15 min. The
RNA was reverse transcribed using oligo(dT) primers at 42°C for 50 min, and
reactions were terminated by heating at 70°C for 15 min. The reverse-transcribed
products were treated with RNase H for 20 min at 37°C and amplified using the
following primer sets. Primers TF-F (59TCCTGCTCGGCTGGGTCTTCGCCC
AG39) and TF-R (59TGTTCGGGAGGGAATCACTGCTTGAACAGT39)
were designed to amplify a 601-bp product within the human tissue factor gene.
Primer GFP-R (59TCGCCCTCGCCGGACACGCTGAACT39) within the
EGFP gene and primer GFP-F (59CCACCATGGTGAGCAAGGGCGAGGA
GC39) located 29 to 55 nt downstream of the predicted UL127 TATA box
sequence were designed to yield a 714-bp product. Primer GFP-R and primer
UL127-TATA (59CTATATAACCAATGGATCTGCTAGCGC39), located within
the predicted UL127 TATA box sequence, were designed to either fail to detect
a product if the predicted TATA box was used or yield a 650-bp product in the
case that an alternative TATA box upstream the predicted UL127 TATA box
was used. PCRs were optimized using the HCMV recombinant BAC genomes as
templates. Similar levels of PCR products were obtained for all the HCMV
recombinant BACs when primer sets GFP-F/GFP-R and GFP-R/UL127 TATA
were used (data not shown). PCRs were performed under the following condi-
tions: 1 cycle at 94°C for 3 min, 30 cycles of 1 min at 94°C, 1 min at 58°C, and 1
min at 72°C, and 1 cycle at 72°C for 10 min. Amplified products were separated
on a 1% agarose gel and visualized by ethidium bromide staining.
Flow cytometry. HFF cells were infected with different HCMV recombinants
at an MOI of 0.5 PFU/cell. On day 3 after infection, cultures were trypsinized,
washed twice with phosphate-buffered saline (PBS) and fixed with 1% formal-
dehyde in PBS. Fluorescence was measured by flow cytofluorometry (fluores-
cence-activated cell sorting [FACS]) using a FACScan (Becton Dickinson,
Mountain View, Calif.). A total of 10,000 events were collected per sample.
Uncompensated fluorescence values from FL1 (GFP fluorescence, 530-nm band
pass filter) and FL2 (autofluorescence; a 585-nm band pass filter) were collected
along with forward angle light scatter (FSC) and side scatter (SSC) for every
event. The data files were subsequently gated employing a logical gate drawn in
a dot plot display of FSC versus SSC to exclude dead cells, debris, and clumps.
For each data file, the resultant gated data set was displayed as a dot plot of FL2
versus GFP fluorescence and a static second region drawn around the GFP-
positive (GFP1) cells, with a static third region drawn around the negative cells
for the purpose of calculating statistics among the data files. The spectral dif-
ferences among GFP1 and negative cells make them easy to distinguish in the
bivariate display, whereas the population overlap as viewed from a single pa-
rameter histogram makes it difficult to distinguish the dull GFP1 from high
autofluorescence.
Confocal laser microscopy. HFF cells seeded onto coverslips were infected
with the different HCMV recombinants at an MOI of 0.5 PFU/cell. On day 3
after infection, infected cells were fixed and permeabilized with 4% paraformal-
dehyde, 0.2% glutaraldehyde, and 0.2% Triton X-100 in PBS. Cells were incu-
bated with HCMV IE monoclonal antibody 810 (dilution 1:60) for 1 h at 37°C.
The coverslips were extensively washed with PBS containing 1% bovine serum
albumin and incubated with a secondary antibody, tetramethyl rhodamine iso-
thiocyanate-(TRITC)-conjugated goat anti-mouse (dilution 1:400; Sigma Immu-
nochemicals). After a further 60-min incubation at 37°C, the coverslips were
washed again with PBS containing 1% bovine serum albumin, rinsed with water,
and mounted using Permount. Samples were examined using a Zeiss Axioplan
confocal microscope and a 633 oil immersion objective lens. Data were collected
at a resolution of 512 by 512 pixels. Data sets were processed using the MRC
1024 software and then exported for preparation for printing using Adobe Pho-
toshop.
RESULTS
Sequences upstream of the NF-1 cluster mediate transcrip-
tional repression of the UL127 promoter site. Evidence for
direct repression of the MIEP by its own IE2 gene product has
been provided to account for the restricted expression of the
IE genes in the later stages of infection (14, 30, 31, 34, 38, 39,
42). This repression system is defined by the competitive bind-
ing of the IE repressor with the RNA polymerase II recruit-
ment step (31, 42). Our previous studies indicated that a strict
requirement for this type of repression is that the position of
the repressor binding site should be in the vicinity of the
transcription start site (31). In other studies, binding sites 59
proximal to a TATA box have also been shown to block the
recruitment of an RNA polymerase II complex (reviewed in
reference 1). The UL127 promoter is located in the center of
the NF-1 cluster in which one NF-1 binding site exists 14 bp
downstream of the UL127 TATA box in the immediate vicinity
of the start site and another lies 10 bp upstream of the TATA
box (25, 27). It is possible that these particular TATA proximal
NF-1 sites may play a role in maintaining a repressed state. To
investigate whether these NF-1 sites are involved in repression,
we examined constructs in which promoter-proximal down-
stream and upstream NF-1 binding sites have been eliminated.
Different cell types were cotransfected with an internal control
standard and reporter plasmids with the CAT gene under the
control of the UL127 promoter with or without the NF-1
binding sites. In the transient transfection assays, the wt UL127
promoter construct pSnaB-BamCAT (containing sequences
between nt 2243 and 2741 of the MIEP) did not show any
significant CAT activity in a variety of cell types (Fig. 2) despite
the presence of the MIEP enhancer. The construct pSnaB-
Bam(HI)CAT lacking the downstream NF-1 binding site also
failed to develop significant promoter activity [Fig. 2; compare
CAT responses for pSnaB-BamCAT and pSnaB-Bam(HI)
FIG. 3. Identification of the sequences that mediate transcriptional repression of the UL127 promoter. (A) Binding of various transcription factors (marked by open
boxes) to HCMV-MIEP sequences between 2244 and 2710 (based on DNase I footprinting data [reviewed in reference 20]). The location of the UL127 TATA box
is shown. Numbers refer to nucleotide positions relative to the transcription start site (11) of the MIEP. Luciferase (LUC) reporter constructs with various 59 and 39
deletion endpoints are shown below. (B) HeLa and NT-2/D1 cells were transfected with 5 mg of the various promoter deletion luciferase constructs shown in panel A
together with 5 mg of the control plasmid pRL-tk. Cell lysates were prepared 30 h after transfection and assayed for luciferase activity. The activity of each promoter
deletion reporter construct was normalized to the activity of the internal control plasmid. A plot of the normalized percentage of luciferase activity calculated for each
construct, taking as 100 the activity presented by pGL3(2531), is shown. The luciferase values shown represent the average 6 standard deviation (bars) of three
determinations.
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CAT]. In addition, pGACC(2673), a reporter plasmid that
contains neither downstream nor upstream NF-1 sites, was
found to be equally ineffective in developing detectable levels
of reporter gene expression [Fig. 2; compare CAT responses
for pSnaB-BamCAT and pGACC(2673)]. While these exper-
iments do not unequivocally exclude the possible involvement
of NF-1, it appears that repression is not due to promoter-
proximal NF-1 binding sites, indicating that additional cis-act-
ing repression sequences might be involved. In agreement with
this suggestion and in marked contrast to deletion of the NF-1
sites described above, deletion of sequences further upstream
(to nt 2531 relative to the MIEP transcription start site) re-
sulted in high levels of reporter gene expression in a variety of
different cell types [Fig. 2; compare CAT responses for pSnaB-
BamCAT and pGACC(2531)]. It is noteworthy that the level
of reporter gene activity is less than that observed with the
MIEP enhancer constructs (A. Angulo and P. Ghazal, unpub-
lished data). The reason for this lower activity is not known,
but it may be due to removal of positive elements in the
deletion constructs and/or presence of further repressor ele-
ments. Alternatively, the UL127 promoter may require viral
factors for maximal activity. Nevertheless, the results of these
experiments raise the possibility that sequences located 160-bp
upstream of the UL127 promoter mediate strong repression of
the UL127 promoter site.
UL127 promoter-proximal upstream sequences block en-
hancer activation. We next examined in more detail the UL127
promoter-proximal upstream sequences involved in mediating
transcriptional repression. Accordingly, a series of 59 and 39
deletion mutants (from nucleotide positions between 2531
and 2691) were constructed and tested for their effects on
reporter (luciferase) activity in transient transfection experi-
ments. The locations of the deletion endpoints are shown in
Fig. 3A in nucleotide positions relative to the initiation site
(11) of the MIEP. In transient transfection assays, deletion of
sequences between 2691 and 2634, in pGL3(2634), did not
alter reporter activity in these cell lines [Fig. 3B; compare
luciferase responses for pGL3(2673) and pGL3(2634)].
When additional sequences between 2634 and 2604 were
deleted, an approximately 10-fold increase in reporter activity
was detected [Fig. 3B; compare luciferase responses for
pGL3(2673) and pGL3(2604)]. Significantly, when the con-
struct pGL3(2581), which has an additional 23-bp region de-
leted, was analyzed in transient transfection assays, a further
threefold increase in luciferase activity was observed [Fig. 3B;
compare pGL(2581) and pGL(2604)]. Deletion of sequences
between 2581 and 2556, in pGL3(2556), resulted in levels of
reporter gene activity comparable to the ones exhibited by
pGL3(2531), in which sequences from 2691 to 2531 were
absent (Fig. 3). Altogether, these results indicate that a region
between nt 2556 and 2634 of the MIEP mediates transcrip-
tional repression of the UL127 promoter in a cell-type-inde-
pendent manner.
In good agreement with these results, a 107-bp internal
deletion mutant that eliminated sequences between nt 2531
and 2638, pGL3(D2531/2638), exhibited a 25- to 50-fold en-
hancement in the transcriptional activity compared with
pGL3(2673) (Fig. 3). To verify further the boundary of these
cis-acting repressor sequences, a mutant construct containing a
shorter internal deletion of 78 bp (from nt 2531 to 2609) was
generated (Fig. 3A). Consistent with the observed activity of
pGL3(2604), this construct [pGL3(D2531/2609)] presented a
lower reporter activity than pGL3(D2531/2638), indicating
that sequences between 2609 and 2638 play a role in main-
tenance of the repression state (Fig. 3B). We note that these
constructs collectively accommodate spacing considerations.
For instance, pGL(2604) has deleted 87 bp from the promoter
region, and the spacing difference between the enhancer and
promoter in pGL(2531) and pGL(2531/2609) is 82 bp. In all
cases, in the absence of repressor sequence, the enhancer is
capable of efficiently activating the UL127 promoter in a spac-
ing-independent manner. Altogether, we conclude from these
transient transfection results that sequences between nt 2556
and 2634 cooperate in mediating transcriptional repression of
the UL127 promoter site. These experiments thus identify
within the unique sequence region (usr) a boundary domain as
the unit of transcriptional repression.
To investigate whether these sequences could block en-
hancer activation on a heterologous promoter, the UL127
TATA box region was substituted with a core promoter frag-
ment (from nt 266 to 1112) containing the MIEP TATA box.
For these experiments, three plasmids, pMIEP(266/1112)
CAT, pE(266/1112)CAT, and pEusr(266/1112)CAT, were
constructed (Fig. 4A) and analyzed in transient transfection
assays in a variety of different cells. Figure 4 shows that the
pE(266/1112)CAT reporter construct containing the en-
hancer region (from nt 2240 to 2531) upstream of the core
promoter resulted in a marked increase (from 38- to 88-fold) in
CAT reporter activity in comparison with the construct without
the enhancer [pMIEP(266/1122)CAT]. Strikingly, the con-
struct pEusr(266/1112)CAT, containing 67 bp of additional
sequence from the usr (nt 2531 to 2598) between the en-
hancer and the MIEP TATA box, resulted in approximately
90% inhibition of enhancer-mediated activation of transcrip-
tion [Fig. 4B; compare CAT responses for pE(266/1112)CAT
and pEusr(266/1112)CAT]. These results support the conclu-
sion that boundary element sequences are capable of mediat-
ing repression of enhancer function on a heterologous pro-
moter.
We next sought to evaluate whether this mode of repression
could also be observed in in vitro transcription assays. In these
experiments, reporter plasmids pMIEP(266/1112)CAT, pE
(266/1112)CAT, and pEusr(266/1112)CAT were resected
with EcoRI and assayed in transcription runoff assays using
HeLa cell nuclear extracts. Transcription reactions were nor-
malized to an internal control standard, and the amount of
specific initiation of transcription was quantified by Phospho-
rImager analysis. As shown in Fig. 5B, the template with the
MIEP core promoter [pMIEP(266/1112)CAT] (lane 1) was
transcribed at a much (fivefold) reduced level in comparison
with the enhancer-containing template, pE(266/1112)CAT
(lane 2), indicating the ability of the CMV enhancer to stim-
ulate transcription in vitro, albeit at a level much lower than
observed in vivo. This level of enhancer-mediated activation
was significantly lower than for transcription reactions using
the pEusr(266/1112)CAT template (compare lanes 2 and 3 in
Fig. 5B). Similar inhibition results were obtained with different
concentrations of reporter template (data not shown). These
results suggest that cis-acting sequences within the usr repress
enhancer activated transcription but do not appear to influ-
ence basal promoter activity. This is consistent with the HeLa
cell transfection assay, which indicated a reduction of tran-
scriptional activity by as much as 90% (Fig. 5A). These exper-
iments indicate that it is possible to recapitulate, in part, re-
pression by the boundary domain with the use of an in vitro
transcription system, supporting the notion that these se-
quences may interact with repressor proteins to promote the
process of transcriptional repression.
UL127 promoter-proximal upstream sequences mediate re-
pression of transcription in the context of an HCMV infection.
To determine whether this boundary domain is responsible for
mediating repression of the UL127 promoter in an HCMV-
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infected cell, we constructed a series of HCMV recombinants
containing coding sequences for the GFP under the control of
various UL127 promoter deletion mutants. To generate these
HCMV recombinants, we used the recently described HCMV
BAC system (6). In this system, the HCMV genome has been
cloned and maintained as a BAC in E. coli, whereby viral
progeny can be reconstituted after transfection of the HCMV
BAC into eukaryotic cells permissive for HCMV. For the pur-
pose of these studies, we constructed three independent
HCMV BAC recombinant genomes, UL127-GFP1, UL127-
GFP7, and UL127-GFP10. A schematic representation of pa-
rental HCMV and the HCMV BAC recombinants generated is
shown in Fig. 6A. The recombinant virus, UL127-GFP1, con-
tains the GFP ORF under the control of the UL127 promoter
lacking sequences between nt 2673 and 2691, removing the 59
proximal NF-1 site. Note that in transient transfection assays,
deletion of these sequences did not result in any significant
promoter activity. The second recombinant HCMV BAC,
UL127-GFP10, contains the GFP ORF under the control of
the UL127 promoter lacking sequences between nt 2531 and
2638 (Fig. 6A). Note that UL127-GFP10 also contains a dis-
rupted 59-proximal NF-1 site between nt 2688 and 2676 (see
Materials and Methods). The third HCMV recombinant,
UL127-GFP7, contains the UL127 promoter lacking se-
quences between 2531 and 2691 (Fig. 6A). The structure of
the recombinant BACs generated was verified by extensive
restriction analysis (SalI, SnaBI, and SpeI) and sequencing.
Figure 6B shows the SalI restriction patterns. The DNAs from
the recombinant HCMV BACs were identical to the DNA
from the parental HCMV BAC pHB5 except for the presence
of a new SalI fragment (7.9 to 8.1 kb) in the place of the natural
SalI 7.4-kb fragment. This new fragment was generated, as
predicted, from the introduction of the GFP ORF downstream
of the mutant UL127 promoter sequences (Fig. 6A). These
results indicate that the expected recombination events oc-
curred within the UL127 region of the viral genome. MRC-5
cells were subsequently transfected with the HCMV BAC re-
combinants. Plaques developed in the cultures, and progeny
mutant viruses were recovered from infected cells.
We next sought to examine whether deletion of repressor
sequences within the UL127 promoter, identified in transient
transfection assays, could also lead to an induction of tran-
scription from the UL127 promoter in the context of a viral
infection. For these experiments, RT-PCR was performed us-
ing RNA from cells infected with the recombinant viruses
under study. HFF cells were infected at an equivalent MOI
(0.1 PFU/cell) with the different recombinant viruses and pa-
rental HCMV RVHB5 reconstituted from the BAC plasmid
FIG. 4. Boundary domain sequences within the UL127 promoter confer repression on a heterologous promoter. (A) Schematic representation of constructs
pMIEP(266/1112)CAT, pE(266/1112)CAT, and pEusr(266/1112)CAT. Numbers refer to nucleotide positions relative to the MIEP transcription start site (11,
indicated by an arrow). The enhancer region, the boundary segment, and the core promoter containing the MIEP TATA box are shown. (B) HFF, U373-MG, and
NT-2/D1 cells were transfected with 5 mg of either pMIEP(266/1112)CAT, pE(266/1112)CAT, or pEusr(266/1112)CAT along with 5 mg of the control plasmid
pRSV-b-gal. Transfections and CAT assays were performed as described in the legend to Fig. 2 and in Materials and Methods. A plot of the normalized percentage
of CAT activity calculated for each construct, taking as 1 the activity presented by pMIEP(266/1112), is shown. The CAT values shown represent the average 6
standard deviation (bars) of three determinations.
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pHB5 as a negative control (6). RNA from infected cells was
harvested at 13 hpi, treated with DNase, and reverse tran-
scribed. Two primer sets were designed to detect the presence
of the GFP transcript. Both primer sets contained a common 39
primer within the GFP gene. In the first primer set, the 59
primer was chosen to anneal with sequences 29 to 55 bp down-
stream the predicted UL127 TATA box. This primer pair
should detect a 714-bp product if GFP transcripts were present
in infected cells. In the second primer set, the 59 primer was
designed to anneal with the predicted UL127 TATA box. This
second primer set should either fail to detect a product in
infected cells if the predicted UL127 TATA box was used to
transcribe the GFP gene or yield a 750-bp product in the case
of using an alternative TATA box upstream the predicted
UL127 TATA box. As expected, when cells were infected with
the parental virus RVHB5, which does not contain the GFP
gene, a specific PCR-amplified product was not detected with
any of the two primer sets used (Fig. 7A and B, lane 2).
Similarly, when cells were infected with UL127-GFP1, the re-
combinant virus in which sequences from 2673 to 2691 of the
UL127 promoter were absent, amplified PCR products were
not obtained (Fig. 7A and B, lanes 4). In marked contrast, in
cells infected with UL127-GFP7 and 210, the expected 714-bp
PCR product resulting from amplification of GFP sequences
using the first primer set was easily detected (Fig. 7A, lanes 6
and 8). However, RT-PCR performed on HFF cells infected
with these two viral recombinants using the second primer set
that contained the primer designed to anneal within the pre-
dicted UL127 TATA box did not yield significant levels of an
amplified product (Fig. 7B, lanes 6 and 8). These data show
that sequences between 2531 and 2638 (relative to the MIEP)
play an important role in the blockage of the UL127 promoter
in the context of a viral infection. In addition, these results
indicate that transcription in cells infected with recombinant
viruses lacking the boundary repressor sequences predomi-
nantly originates approximately 30 bp downstream the UL127
promoter TATA box. Interestingly, transcripts derived from
FIG. 5. Boundary domain sequences within the UL127 promoter mediate
repression in an in vitro transcription system. (A) HeLa cells were transfected
with 5 mg of either pMIEP(266/1112)CAT (lane 1), pE(266/1112)CAT (lane
2), or pEusr(266/1112)CAT (lane 3) along with 5 mg of the control plasmid
pRSV-b-gal. Transfections and CAT assays were performed as described in the
legend to Fig. 2 and in Materials and Methods. A plot of the normalized
percentage of CAT activity calculated for each construct, taking as 1 the activity
presented by pMIEP(266/1112), is shown. (B) In vitro runoff transcription
assays with different DNA templates, pMIEP(266/1112)CAT (lane 1), pE(266/
1112)CAT (lane 2), and pEusr(266/1112)CAT (lane 3), linearized with EcoRI.
The transcription reactions were performed, processed, and subjected to poly-
acrylamide gel electrophoresis (18). The 360-nt specific runoff transcript is indi-
cated by an arrow. The specific runoff transcripts were normalized to an internal
control, and the amount of transcript was determined by PhosphorImager anal-
ysis (42). A plot of the normalized percentage of specific transcription for each
DNA template, taking as 100 the activity developed by pE(266/1112)CAT, is
shown.
FIG. 6. Construction of UL127-GFP HCMV BAC recombinant genomes.
(A) The top line represents the parental (wt) HCMV genome with the SalI
fragment (nt 169746 to 177147 [11]) containing the MIE region expanded below.
Sequences corresponding to the enhancer and usr (open rectangle) and the
UL127 ORF (black box) are indicated. Recombinant HCMV BAC genomes,
UL127-GFP1, UL127-GFP10, and UL127-GFP7, containing the GFP ORF
(open rectangle) under the control of the various UL127 promoter deletion
mutants are shown. UL127 promoter deletions are indicated by black boxes, and
the coordinates for these deletions relative to the HCMV ie1/ie2 transcription
start site are shown. The diagram is not drawn to scale. (B) Ethidium bromide-
stained agarose gels of SalI-digested BAC plasmids UL127-GFP1, UL127-
GFP10, UL127-GFP7, and parental HCMV BAC (pHB5) after separation on a
0.5% agarose gel. Positions of size markers are shown at the right; sizes of the
natural and new SalI fragments for each virus are shown with arrows.
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the UL127 promoter are cycloheximide sensitive, indicating
early expression kinetics instead of the anticipated IE expres-
sion (data not shown).
To further corroborate whether sequences within the UL127
promoter repress transcription in the context of a viral infec-
tion, we examined GFP reporter activity using confocal micros-
copy and FACS. In the first experiments, HFF cells were in-
fected at an MOI of 0.5 PFU/cell with recombinant viruses
UL127-GFP1, UL127-GFP7, and UL127-GFP10 and parental
HCMV RVHB5. On day 3 postinfection, cells were fixed, pre-
pared for immunofluorescence analysis using a monoclonal
antibody specific for the MIE proteins and a secondary anti-
body conjugated to TRITC, and visualized by confocal micros-
copy. As expected, when cells were infected with the parental
virus RVHB5, only nuclear staining due to the expression of
the MIE proteins could be observed (Fig. 8, panels 1A and
2A). When cells were infected with UL127-GFP1, with se-
quences from 2673 to 2691 of the UL127 promoter deleted,
GFP fluorescence was not detectable, while cells were clearly
positive for expression of the MIE proteins (compare panels
1B and 2B in Fig. 8). In marked contrast, infection of HFF
with UL127-GFP7 and UL127-GFP10 resulted in significant
amounts of GFP expression. Confocal microscopy images
showed that infected HFF cells simultaneously exhibited nu-
clear staining due to the MIE proteins and expressed GFP in
the nucleus and cytoplasm (Fig. 8, panels C1 to -3 and D1 to
-3). Therefore, sequences between 2531 and 2638 (relative to
the MIEP) are sufficient in shutting off the UL127 promoter in
the context of a viral infection in cells where the divergent MIE
promoter is strongly active.
In the next set of experiments, we quantified the levels of
reporter activity by directly measuring GFP levels. For these
experiments, we infected HFF cells at an MOI of 0.5 PFU/cell
with the different recombinant viruses and measured fluores-
cence on day 3 postinfection by flow cytofluorometry. Figure 9
shows that while all cells were GFP negative after infection
with UL127-GFP1 (mean fluorescence intensity with a signal-
to-noise ratio of 1.3), HFF cells infected with UL127-GFP7
exhibited approximately twofold-higher levels of GFP in com-
parison with UL127GFP10-infected cells (compare mean flu-
orescence intensities with signal-to-noise ratios of 7.2 and 14.1
for UL127-GFP10 and UL127-GFP7, respectively). These re-
sults indicate that maximal derepression of the UL127 pro-
moter in the context of the viral infection requires the removal
of sequences from 2531 to 2673. Thus, these data are consis-
tent with the role of sequences between 2556 and 2638 of the
UL127 promoter as a repressor of gene expression in transient
transfection assays. However, sequences between 2638 and
2673 also appear to contribute to the level of repression of the
UL127 promoter but only in the context of an HCMV infec-
tion.
DISCUSSION
We have presented evidence for the presence of a boundary
domain located within the usr of the HCMV MIEP, whereby
the putative UL127 promoter is prevented from being acti-
vated by the potent CMV enhancer. The borders of the bound-
ary domain are positioned between the UL127 TATA box and
the enhancer. Our experiments define a region between 2556
and 2638 (relative to the MIEP start site) that functions to
dramatically repress enhancer activation of transcription at the
UL127 promoter site both in transient transfection assays and
in the context of virus infection. In addition, sequences be-
tween 2638 and 2673 were found to contribute to the level of
repression only in the context of virus infection but not in
transient transfection experiments.
Previously, DNase I protection experiments with DNA frag-
ments encompassing usr sequences demonstrated (18), on the
basis of different chromatographic behavior, the interaction of
multiple distinct factors. Later experiments identified one of
these binding components as composed of a retinoic acid re-
ceptor-retinoid X receptor (RAR-RXR) heterodimer (2).
While DNA-bound RAR-RXR complexes are known to re-
cruit transcriptional corepressors in the absence of bound li-
gand (12, 29), our mapping studies show that this site is not
required for mediating repression. Sequences immediately ad-
jacent to the RAR-RXR site, between nt 2558 and 2602
(relative to the MIEP), interact with a complex of proteins that
have similar chromatographic behavior (18) (Fig. 10). These
sequences resemble binding sites for the forkhead/winged helix
family of transcription factors (8, 16, 32). Many members of
this family are known to be potent repressors of transcription.
These observations suggest that one of the candidate repressor
elements may bind a cluster of winged helix repressors, al-
though our results indicate that the repression domain is not
limited to these sites alone (Fig. 10). For instance, the binding
site between 2604 and 2632 participates in mediating repres-
sion and is known to interact with a factor that shares charac-
teristics of the CTF family but is distinct from NF-1 (18) (Fig.
FIG. 7. Detection of GFP transcripts in HFF cells infected with UL127-GFP HCMV recombinants. HFF cells were infected at an MOI of 0.1 with parental HCMV
(RVHB5; lanes 1 and 2), UL127-GFP1 (lanes 3 and 4), UL127-GFP10 (lanes 5 and 6), and UL127-GFP7 (lanes 7 and 8). Total RNA was harvested at 13 hpi, treated
with DNase, and reverse transcribed by using oligo(dT). PCR was performed using three different primer sets: one containing a 39 primer that anneals within the GFP
gene, GFP-R, and a 59 primer situated 29 to 55 bp downstream the predicted UL127 TATA box, GFP-F (A); one containing primer GFP-R and a 59 primer located
within the predicted UL127 TATA box, UL127-TATA (B), and one specific for the human tissue factor gene (C). Amplified products were separated on a 1% agarose
gel and visualized by ethidium bromide staining. Shown are products obtained in reactions containing RT (lanes 2, 4, 6, and 8) and in control reactions in which RT
was not added (lanes 1, 3, 5, and 7). Position of size markers are shown at the left; sizes of the amplified products are indicated by arrows.
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10). In addition, sequences (2638 to 2673) between the CTF-
like binding site and the NF-1 site proximal to the UL127
TATA box also appear to contribute to repression only in the
context of the virus (Fig. 10). This region is not known to
interact strongly with any nuclear factors but contains weak
binding sites for YY1 (from nucleotide positions 2675 to 2663
and 2655 to 2642), a factor also known to mediate transcrip-
tional repression (T. Stamminger, personal communication).
Recently, Lundquist and coworkers presented work on the
characterization of a repressor region located upstream of the
UL127 promoter (33). They found that sequences between
2640 and 2694 contribute to strong repression, while se-
quences between 2583 and 2640 effected repression to a
much lesser extent in the context of the viral infection. The
results of our study are in agreement with theirs regarding the
presence of a repressor region but differ markedly in the pre-
cise sequences shown to be important in mediating the shutoff
of UL127 expression. We believe that the conclusions drawn
from these two independent studies are complementary. In
particular, it is likely that the reason for the weaker repression
observed by Lundquist et al. (33) for the distal repression
sequences (2583 to 2640) is that repression sequences be-
tween nt 2556 and 2583 were not removed. Indeed, resection
of sequences between 2556 and 2638 in the context of an
infection leads to a dramatic relief of repression (this study).
Also in agreement with the work by Lundquist et al. (33), we
found that sequences closer to the UL127 TATA box contrib-
ute to repression but only in the context of the virus. However,
we note that removal of sequences between nucleotide posi-
tions 2673 and 2691 alone was not sufficient, in our study, to
effect activation of the UL127 promoter. Therefore, while our
results are different and agree only in part, they are highly
complementary.
We note that the inability of the boundary region to repress
the MIEP over a relatively large distance is compatible with a
short-range repression mechanism (21). In this case, binding of
repressors to promoter-proximal elements results in the dom-
inant inhibition of a promoter site by upstream activators.
Boundary elements have been identified in numerous drosoph-
ila and yeast genes (references 22, 26, and 40 and references
therein), but few if any have been formally characterized for
mammalian genes. In drosophila, short-range repressors have
been elegantly shown to provide flexibility in controlling com-
plex genetic loci. Indeed, Gray and coworkers (23) proposed
that short-range repression is central for the evolution of com-
plex promoters that are composed of multiple, autonomous
regulatory elements as is prominently exhibited by the CMV
MIEPs. Although the nature of the enhancer-repressor-pro-
FIG. 8. Confocal microscopy of HFF cells infected with UL127-GFP HCMV recombinants. HFF cells were infected with parental HCMV (RVHB5; A),
UL127-GFP1 (B), UL127-GFP10 (C), and UL127-GFP7 (D) at an MOI of 0.5 PFU/cell. Three days after infection, cells were fixed, permeabilized, and subjected to
immunofluorescence using an HCMV IE monoclonal antibody and a TRITC–anti-mouse secondary conjugate. Expression of MIE proteins can be visualized in panels
1 (red), expression of GFP is evident in panels 2 (green), and panels 3 show the merge of panels 1 and 2. Magnification, 363.
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moter interaction is unclear, the results of this study indicate
that the viral boundary domain blocks enhancer activation in a
disproportional manner. In other words, there are far more
activators bound to the enhancer region than there are poten-
tial repressor binding sites in the boundary region. There are
several possible explanations for the ability of a limited repres-
sor complex to block many activators, some of which challenge
our view of how enhancers work. Perhaps the boundary do-
main recruits by protein-protein interaction a multifactor re-
pression complex that is able to interfere with many activators.
Alternatively, it is possible that multiple activators present in
the enhancer coordinate communications with the basal tran-
scription machinery by interacting with a central switching
(adapter/nodal) complex. In this scenario, the boundary do-
main might disrupt the ability of the adapter/node to interact
with the promoter. It should be noted that there is a precedent
for a central switching unit in coordinating interactions with all
other cis-acting regulatory modules, as demonstrated by the
Endo16 system of the sea urchin embryo (43). In this example,
module A of the Endo16 cis-regulatory system communicates
FIG. 9. GFP expression from UL127 GFP HCMV recombinants. HFF cells were infected with UL127-GFP1, UL127-GFP10, and UL127-GFP7 at an MOI of 0.5
PFU/cell. On day 3 postinfection, cells were trypsinized and fixed with 1% formaldehyde. Fluorescence was measured by flow cytofluorometry as described in Materials
and Methods. A histogram of FL1 versus the log fluorescence intensity (detected at 530 nm) is shown. A total of 10,000 events were collected for each sample. Mean
fluorescence intensities with signal-to-noise ratios of 25.4/19.8, 134.6/18.8, and 222.1/15.8 were obtained for UL127-GFP1, UL127-GFP10, and UL127-GFP7,
respectively.
FIG. 10. Sites of protein-DNA interaction on MIEP sequences between 2538 and 2738. Sequences between 2556 and 2638, corresponding to the repressor region
defined in transient transfection assays, are marked by reverse print. Sequences from 2638 to 2673, shown to contribute to repression of the UL127 promoter in the
context of the infection, are marked by a gray box. Black underlining represents the extent of strong protection observed using the phosphocellulose (p11) gel
chromatography fractions P11 0.3, P11 0.6, and P11 1 (18). The cellular factors known to interact with the protected sequences are indicated. The UL127 TATA box
is shown. Numbers refer to nucleotide positions relative to the transcription start site (11) of the MIEP.
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the status of the whole regulatory system directly to the basal
transcription machinery. All upstream sites work through mod-
ule A and in the endogenous arrangement do not themselves
interact directly with the basal transcription apparatus.
In conclusion, we have shown that repression can play an
important role in determining the ability of the enhancer to
activate transcription. Until now the usr was characterized as a
positive control region for the MIEP (2, 18). We now show that
the ability of the HCMV enhancer to bidirectionally activate
transcription is stringently regulated in a negative manner by a
boundary domain. This work thus provides a molecular expla-
nation for limiting the action of the enhancer to the MIEP.
Restricting the boundary of action of the CMV enhancer is
likely to have important biological implications for ensuring
sequential and coordinate regulation of transcription. It may
not be advantageous or may even be deleterious to the virus to
have genes, other than select IE genes, influenced by the prox-
imal and long-range effects of an innately strong enhancer. The
identification of the repressor proteins and target sequences,
the precise mechanism for effecting inhibition, and the func-
tional consequences of altered physiological states on UL127
promoter activation are topics that remain to be explored.
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